TOP HEADLINES

Featured Story

New Jersey compounder indicted over unsanitary manufacturing

The FDA has decided that not only were the operations of New Jersey-based Med Prep Consulting unsterile, they were illegal.

Unused Forest Labs facility snapped up by Aprecia Pharmaceuticals

Pennsylvania-based Aprecia Pharmaceuticals this week announced its intention to purchase a never-used facility in Blue Ash, OH, built by Forest Laboratories in 2013.

Federal judge cuts off Maine's Internet drug supply chain

The ability of Maine consumers to get cheaper drugs from across the Canadian border has been on-again and off-again. Now it is off again.

Bharat, Serum Institute ramp up production of their swine flu vaccines

Two Indian vaccinemakers are ramping up production of their swine flu vaccines, to replace stocks that were destroyed recently after they expired.

Lupin plant hit with Form 483 but continues to rack up approvals

The FDA has sent a Form 483 to Lupin listing 6 observations its inspectors made during a visit to one of the company's production plants in central India last month. However, the ticking off has done little to slow the rate of approvals for the facility, which has racked up two site transfer nods and one ANDA go-ahead since receiving the Form 483.

MORE NEWS

From Our Sister Sites

FierceAnimalHealth

Petaluma, CA-based Oculus Innovative Sciences announced Thursday that it has launched an animal health unit and 6 new products for the treatment of wounds, skin and eyes.

FierceMedicalDevices

St. Jude Medical agreed to pay as much as $14.25 million to settle about 950 claims related to its Riata defibrillator leads. The wires used to shock a heart that is beating abnormally degraded in as few as four years and were pulled from the market in 2010.